Michael A. Rossi
First SEC filing: Jan. 3, 2023 · Latest: Jan. 3, 2023
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 29, 2022 | HBIO | F | 3,035 | $2.55 | $7,739 | 260,540 Direct | -1.15% | Disposed | -67.3% (price as of 2026-10-02) |
| Dec. 29, 2022 | HBIO | F | 3,763 | $2.55 | $9,596 | 263,575 Direct | -1.41% | Disposed | -67.3% (price as of 2026-10-02) |
| Dec. 29, 2022 | HBIO | F | 3,162 | $2.55 | $8,063 | 267,338 Direct | -1.17% | Disposed | -67.3% (price as of 2026-10-02) |
| July 18, 2022 | HBIO | F | 7,008 | $3.63 | $25,439 | 270,500 Direct | -2.53% | Disposed | -77.0% (price as of 2026-10-02) |
| June 11, 2022 | HBIO | F | 6,325 | $3.95 | $24,984 | 277,508 Direct | -2.23% | Disposed | -78.9% (price as of 2026-10-02) |
| March 1, 2022 | HBIO | A | 28,716 | · | · | 283,833 Direct | +11.26% | Acquired | (price as of 2026-10-02) |
| March 1, 2022 | HBIO | A | 31,021 | · | · | 255,117 Direct | +13.84% | Acquired | (price as of 2026-10-02) |
| Dec. 29, 2021 | HBIO | F | 3,763 | $7.27 | $27,357 | 224,096 Direct | -1.65% | Disposed | -88.5% (price as of 2026-10-02) |
| Dec. 29, 2021 | HBIO | F | 3,163 | $7.27 | $22,995 | 227,859 Direct | -1.37% | Disposed | -88.5% (price as of 2026-10-02) |
| July 18, 2021 | HBIO | F | 6,966 | $7.57 | $52,733 | 231,022 Direct | -2.93% | Disposed | -89.0% (price as of 2026-10-02) |
| June 11, 2021 | HBIO | F | 6,172 | $7.64 | $47,154 | 237,988 Direct | -2.53% | Disposed | -89.1% (price as of 2026-10-02) |
| June 11, 2021 | HBIO | A | 21,546 | · | · | 244,160 Direct | +9.68% | Acquired | (price as of 2026-10-02) |
| March 1, 2021 | HBIO | A | 36,876 | · | · | 222,614 Direct | +19.85% | Acquired | (price as of 2026-10-02) |
| March 1, 2021 | HBIO | A | 38,462 | · | · | 185,738 Direct | +26.12% | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2020 | HBIO | F | 3,744 | $4.29 | $16,062 | 147,276 Direct | -2.48% | Disposed | -80.6% (price as of 2026-10-02) |
| July 18, 2020 | HBIO | A | 23,877 | · | · | 157,814 Direct | +17.83% | Acquired | (price as of 2026-10-02) |
| July 18, 2020 | HBIO | F | 6,794 | $3.42 | $23,235 | 151,020 Direct | -4.31% | Disposed | -75.6% (price as of 2026-10-02) |
| June 11, 2020 | HBIO | A | 43,092 | · | · | 90,845 Direct | +90.24% | Acquired | (price as of 2026-10-02) |
| June 11, 2020 | HBIO | A | 43,092 | · | · | 133,937 Direct | +47.43% | Acquired | (price as of 2026-10-02) |
| June 11, 2020 | HBIO | A | 92,896 | · | · | 92,896 Direct | · | Acquired | (price as of 2026-10-02) |
| July 18, 2019 | HBIO | A | 111,842 | · | · | 111,842 Direct | · | Acquired | (price as of 2026-10-02) |
| July 18, 2019 | HBIO | A | 47,753 | · | · | 47,753 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 11, 2020 | HBIO | Stock option (right to buy) | Common Stock | $2.63 | June 11, 2027 | 92,896 | Acquired |
| July 18, 2019 | HBIO | Stock option (right to buy) | Common Stock, par value $0.01 per share | $1.78 | July 18, 2029 | 111,842 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $340,000 | · | · | · | · | · | · | $682,746 |
| 2021 | $340,000 | · | $340,000 | · | $115,600 | · | $23,150 | $818,750 |
| 2020 | $340,000 | $63,798 | $241,752 | $113,333 | · | · | $19,278 | $778,161 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.